Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + cyclophosphamide in metastatic or unresectable chondrosarcoma and myxoid liposarcoma
NL-OMON47217Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus and cyclophosphamide in chondrosarcoma and Myxoid/round cell liposarcoma (MRCLS), sponsored by Leiden University Medical Center. Primary endpoint: Time to progression. Started Dec 2014; status: completed.
02
Drugs
sirolimuscyclophosphamide
03
Conditions
chondrosarcomaMyxoid/round cell liposarcoma (MRCLS)
Beyond the preview
Go deeper on NL-OMON47217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47217.